This is a prospective observational study for long-term clinical evaluation (minimum 4-year follow-up) in patients treated within the research protocol "OA-bi-blind" (Double-blind randomized trial on the treatment of bilateral knee osteoarthritis: Autologous bone marrow concentrate VS. hyaluronic acid)
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Knee Injury and Osteoarthritis Outcome Score (IKDC)-Subjective Knee Evaluation Form
Timeframe: baseline
Knee Injury and Osteoarthritis Outcome score- (KOOS Score)
Timeframe: baseline
EuroQol Visual Analogue Scale (EQ-VAS )
Timeframe: baseline
Tegner Score
Timeframe: baseline
EQ-5D (EuroQoL) Current Health Assessment
Timeframe: baseline
Patient Acceptable Symptom State (PASS)
Timeframe: baseline
Visual Analogue Scale (VAS)
Timeframe: baseline
Final treatment opinion
Timeframe: baseline
Failure
Timeframe: baseline